Sign in

CIK 0001388320

  • Non-accelerated filer
  • Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880378336
Phone
+1 646-677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Chairman & CEO bought 33,333 shares at $0.75 ($25,000)
  3. 4 Open-market buy Executive Vice President bought 10,000 shares at $0.75 ($7,500)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Chief Medical Officer bought 5,000 shares at $1.11 ($5,550)
  6. 4 Open-market buy Chairman and CEO bought 7,500 shares at an average $1.16 ($8,725)
  7. 4 Open-market buy Principal Financial Officer bought 3,500 shares at $1.17 ($4,095)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Executive Chairman bought 5,000 shares at $0.88 ($4,400)
  18. 4 Open-market buy Executive Chairman bought 5,000 shares at $0.98 ($4,900)
  19. 4 Open-market sale 10% owner sold 192,927 shares at an average $1.83 ($352,372)
  20. 4 Open-market sale 10% owner sold 50,000 shares at an average $1.71 ($85,495)

Page 5 of 8 · 146 filings